Optimization of Health Expenditure in Liver Surgery
1 other identifier
observational
3,000
1 country
11
Brief Summary
The aim of this study is to reduce the length of stay after liver surgery by taking account of objective quantitative clinical variables, subjective qualitative clinical variables and non clinical variables.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2012
Longer than P75 for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 22, 2012
CompletedFirst Posted
Study publicly available on registry
October 29, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedFebruary 6, 2017
February 1, 2017
5.3 years
October 22, 2012
February 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
overall postoperative length of stay
the overall postoperative length of stay is defined as the hospitalization between the surgery and patient's discharge. This period includes the readmission for at least 24 hours in case of outcomes related to the surgery.
during the 3 months after the surgery
Secondary Outcomes (4)
peroperative outcomes
during the surgical procedure
postoperative outcomes
after the surgery until postoperative month 3
construct of pronostic models
after the postoperative month 3
evaluation of PMSI indicators
after the postoperative month 3
Study Arms (1)
operated patients
this cohort includes patients who underwent a liver surgery whatever the pathology and whatever the surgical procedure
Interventions
this intervention type includes hepatectomies; wedge; segmentectomies etc...
Eligibility Criteria
the population corresponds to patients operated in one of the thirteen hospitals. These hospitals are distributed on the french territory to ensure that the recruitment is representative of the general population
You may qualify if:
- elective liver surgery
- older than 18
- agreed to participate
- surgical procedure included procedures registered as "HLFA003 - 007 ; 009 - 011 ; 017 - 020 ; HLFC002 à 004 ; 027 ; 032 ; 037" in the PMSI database
You may not qualify if:
- emergency surgery
- refused to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
Amiens North Hospital
Amiens, France
Bordeaux Hospital
Bordeaux, France
Beaujon University Hospital
Clichy, France
Lille Regional Hospital
Lille, France
Lyon Hospital
Lyon, France
Marseille Hospital
Marseille, France
Paoli calmette institute
Marseille, France
Saint Antoine Hospital
Paris, France
Strasbourg hospital
Strasbourg, France
Gustave Roussy institute
Villejuif, France
Paul Brousse Hospital
Villejuif, France
Related Publications (1)
Cauchy F, Farges O, Vibert E, Boleslawski E, Pruvot FR, Regimbeau JM, Mabrut JY, Scatton O, Adham M, Laurent C, Gregoire E, Delpero JR, Bachellier P, Soubrane O. Sensitizing Surgeons to Their Outcome Has No Measurable Short-term Benefit. Ann Surg. 2017 Nov;266(5):884-889. doi: 10.1097/SLA.0000000000002403.
PMID: 28991876DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Olivier FARGES, MD, phD
Beaujon University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 22, 2012
First Posted
October 29, 2012
Study Start
September 1, 2012
Primary Completion
December 1, 2017
Study Completion
December 1, 2018
Last Updated
February 6, 2017
Record last verified: 2017-02